answer text |
<p>In line with the guidance governing research, the HIV Pre-Exposure Prophylaxis
(PrEP) Impact Trial is currently unable to provide any detailed breakdown of information
about participants. This is to preserve the integrity of the emerging data. A planned
interim analysis including further demographic breakdown is planned early next year.</p><p>
</p><p>An evaluation report will be available after the completion of the trial in
2021 which is expected to include the facilitators and barriers to accessing HIV pre-exposure
prophylaxis across all groups, including women.</p>
|
|